Feedback / Questions
Erysaa (epoetin alfa biosimilar) - PanGen Biotech, CCM Pharma
PanGen Biotech: Pipeline Update
(PanGen Biotech)
-
Jun 6, 2016 -
Anticipated filing for approval for anemia in Korea and Malaysia in Q4 2016
Anticipated non-US regulatory
•
Biosimilar
http://www.pangen.com/eng/menu3_2.php
Jun 6, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious